These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 29215041)

  • 41. Oncogenic Human Papillomavirus: Application of CRISPR/Cas9 Therapeutic Strategies for Cervical Cancer.
    Zhen S; Li X
    Cell Physiol Biochem; 2017; 44(6):2455-2466. PubMed ID: 29268281
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Single CRISPR-Cas9 Deletion Strategy that Targets the Majority of DMD Patients Restores Dystrophin Function in hiPSC-Derived Muscle Cells.
    Young CS; Hicks MR; Ermolova NV; Nakano H; Jan M; Younesi S; Karumbayaram S; Kumagai-Cresse C; Wang D; Zack JA; Kohn DB; Nakano A; Nelson SF; Miceli MC; Spencer MJ; Pyle AD
    Cell Stem Cell; 2016 Apr; 18(4):533-40. PubMed ID: 26877224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome Editing by CRISPR/Cas9 in Sorghum Through Biolistic Bombardment.
    Liu G; Li J; Godwin ID
    Methods Mol Biol; 2019; 1931():169-183. PubMed ID: 30652290
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Editing of the Bacillus subtilis Genome by the CRISPR-Cas9 System.
    Altenbuchner J
    Appl Environ Microbiol; 2016 Sep; 82(17):5421-7. PubMed ID: 27342565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pre-clinical non-viral vectors exploited for
    Rouatbi N; McGlynn T; Al-Jamal KT
    Biomater Sci; 2022 Jun; 10(13):3410-3432. PubMed ID: 35604372
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Improvement of baculovirus as protein expression vector and as biopesticide by CRISPR/Cas9 editing.
    Pazmiño-Ibarra V; Mengual-Martí A; Targovnik AM; Herrero S
    Biotechnol Bioeng; 2019 Nov; 116(11):2823-2833. PubMed ID: 31403180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
    Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
    Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice.
    Li L; Song L; Liu X; Yang X; Li X; He T; Wang N; Yang S; Yu C; Yin T; Wen Y; He Z; Wei X; Su W; Wu Q; Yao S; Gong C; Wei Y
    ACS Nano; 2017 Jan; 11(1):95-111. PubMed ID: 28114767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Novel System for Simple Rapid Adenoviral Vector Construction to Facilitate CRISPR/Cas9-Mediated Genome Editing.
    Bi Y; Gu L; Wang J; Chang Y; Jin M; Mao Y; Wang H; Ji G
    CRISPR J; 2021 Jun; 4(3):381-391. PubMed ID: 34077671
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Large-scale genome editing based on high-capacity adenovectors and CRISPR-Cas9 nucleases rescues full-length dystrophin synthesis in DMD muscle cells.
    Tasca F; Brescia M; Wang Q; Liu J; Janssen JM; Szuhai K; Gonçalves MAFV
    Nucleic Acids Res; 2022 Jul; 50(13):7761-7782. PubMed ID: 35776127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
    Shen J; Zhou J; Chen GQ; Xiu ZL
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
    [No Abstract]   [Full Text] [Related]  

  • 54. Antiproliferative effects of AAV-delivered CRISPR/Cas9-based degradation of the HPV18-E6 gene in HeLa cells.
    Noroozi Z; Shamsara M; Valipour E; Esfandyari S; Ehghaghi A; Monfaredan A; Azizi Z; Motevaseli E; Modarressi MH
    Sci Rep; 2022 Feb; 12(1):2224. PubMed ID: 35140292
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficient oligo nucleotide mediated CRISPR-Cas9 gene editing in Aspergilli.
    Nødvig CS; Hoof JB; Kogle ME; Jarczynska ZD; Lehmbeck J; Klitgaard DK; Mortensen UH
    Fungal Genet Biol; 2018 Jun; 115():78-89. PubMed ID: 29325827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An efficient DNA- and selectable-marker-free genome-editing system using zygotes in rice.
    Toda E; Koiso N; Takebayashi A; Ichikawa M; Kiba T; Osakabe K; Osakabe Y; Sakakibara H; Kato N; Okamoto T
    Nat Plants; 2019 Apr; 5(4):363-368. PubMed ID: 30911123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effective regeneration of dystrophic muscle using autologous iPSC-derived progenitors with CRISPR-Cas9 mediated precise correction.
    Hagan M; Ashraf M; Kim IM; Weintraub NL; Tang Y
    Med Hypotheses; 2018 Jan; 110():97-100. PubMed ID: 29317080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
    Meng X; Zhou H; Xu S
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficient Genome Editing Achieved via Plug-and-Play Adenovirus Piggyback Transport of Cas9/gRNA Complex on Viral Capsid Surface.
    Lu ZH; Li J; Dmitriev IP; Kashentseva EA; Curiel DT
    ACS Nano; 2022 Jul; 16(7):10443-10455. PubMed ID: 35749339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Supramolecular Nanosubstrate-Mediated Delivery for CRISPR/Cas9 Gene Disruption and Deletion.
    Ban Q; Yang P; Chou SJ; Qiao L; Xia H; Xue J; Wang F; Xu X; Sun N; Zhang RY; Zhang C; Lee A; Liu W; Lin TY; Ko YL; Antovski P; Zhang X; Chiou SH; Lee CF; Hui W; Liu D; Jonas SJ; Weiss PS; Tseng HR
    Small; 2021 Jul; 17(28):e2100546. PubMed ID: 34105245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.